Philipp Mathieu appointed CEO of Immunovia AB
LUND, SWEDEN – Immunovia today announced that Philipp Mathieu has been named Chief Executive Officer and President effective immediately. Since January, Philipp has been acting Chief Executive Officer and President. Commenting on the announcement, Carl Borrebaeck, Chairman, states: “After carefully evaluating external candidates, the board has decided that Philipp with his extensive financial background and experience is the right person to lead Immunovia through the transition from a research-focused company to a successful commercial enterprise. While serving as acting Chief